GE’s 3Q numbers fall
A strengthening financial division and a growing sales backlog portend a brightening future for GE, but the consolidated numbers coming from GE for 3Q were well below par.
GE’s 3Q numbers fall
A strengthening financial division and a growing sales backlog portend a brightening future for GE, but the consolidated numbers coming from GE for 3Q were well below par. In a financial release Oct. 16, the company reported that revenues fell to $37.8 billion, off 20% compared to the previous year’s third quarter, and earnings fell to $2.5 billion, down 51% from the previous year period. A breakdown of data regarding financial performance related to healthcare products and services were not immediately available.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
